Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development

Mustillo, P. J., Sullivan, K. E., Chinn, I. K., Notarangelo, L. D., Haddad, E., Davies, E. G., de la Morena, M. T., Hartog, N., Yu, J. E., Hernandez-Trujillo, V. P., Ip, W., Franco, J., Gambineri, E., Hickey, S. E., Varga, E., & Markert, M. L. (2023). Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. Journal of Clinical Immunology, 43(2), 247–270. https://doi.org/10.1007/s10875-022-01418-y
Authors:
Peter J Mustillo
Kathleen E Sullivan
Ivan K Chinn
Luigi D Notarangelo
Elie Haddad
E Graham Davies
Maria Teresa de la Morena
Nicholas Hartog
Joyce E Yu
Vivian P Hernandez-Trujillo
Winnie Ip
Jose Franco
Eleonora Gambineri
Scott E Hickey
Elizabeth Varga
M Louise Markert
Affiliated Authors:
Joyce E Yu
Author Keywords:
22q11
2 deletion
digeorge syndrome
defects in thymic development
charge syndrome
immunology guidelines
thymic implant
22q11.2 deletion
Publication Type:
Article
Unique ID:
10.1007/s10875-022-01418-y
PMID:
Publication Date:
Data Source:
PubMed

Record Created: